Hexin Instrument (688622) 2023 Third Quarter Report Review: Revenue increased year-on-year, bright medical products continued to advance
Hexin Instrument (688622) 2023 third quarter report review: Domestic mass spectrometry technology leads the third quarter, losses narrowed markedly
Hexin Instruments (688622): Core key technology is autonomous and controllable to help replace domestic production
Hexin Instrument (688622) 2022 Annual Report and 2023 Quarterly Report Reviews: Short-term fluctuations in 2022 operations and market recovery in the first quarter led to a recovery in revenue
Hexin Instrument (688622) 2022 Third Quarter Report Review: Revenue Fluctuates Due to the Impact of the Pandemic, Interest Rate Loans Help the Company Release Instruments
Hexin Instruments (688622): Decline in gross margin drags down improvements in profit product structure
N Hexin (688622): “Specializing in Special and New” Little Giants as Chinese Mass Spectrometry Instruments
N Hexin (688622): The multi-point layout of domestic mass spectrometer leaders is waiting to blossom